Peter Huebener

9PUBLICATIONS
24CO-AUTHORS
Metabolic medicineInnate immunityFood properties (incl. characteristics and health benefits)Predictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 13, 2024
Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical Outcome.

Felix Piecha, Beatrice-Victoria Jahn, Johannes Köntopf

|Jan 29, 2024
Intestinal Epithelia and Myeloid Immune Cells Shape Colitis Severity and Colorectal Carcinogenesis via High-mobility Group Box Protein 1.

Katharina Foelsch, Penelope Pelczar, Elisabeth Zierz

|Oct 21, 2022
A prospective pilot study of a gluten-free diet for primary sclerosing cholangitis and associated colitis.

Timur Liwinski, Sina Hübener, Lara Henze

|Apr 06, 2022
The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver.

Ingmar Mederacke, Aveline Filliol, Silvia Affo

|Sep 24, 2021
Leukocyte-Derived High-Mobility Group Box 1 Governs Hepatic Immune Responses to Listeria monocytogenes.

Annika Volmari, Katharina Foelsch, Elisabeth Zierz

|Sep 20, 2021
Liver transplantation for acute-on-chronic liver failure predicts post-transplant mortality and impaired long-term quality of life.

Lukas Goosmann, Angela Buchholz, Katrin Bangert

Pageof 2